Abstract: The invention features a method of using insulin-like growth factor-I (IGF-I) or insulin-like growth factor-III (IGF-III) to prevent or treat peripheral neuropathy in a mammal.
Type:
Grant
Filed:
December 29, 1994
Date of Patent:
October 29, 1996
Assignees:
Cephalon, Inc., Albert Einstein College of Medicine of Yeshiva University
Inventors:
Michael E. Lewis, Stuart C. Apfel, John A. Kessler